Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2013 Apr 10;19(7):1033–1039. doi: 10.1016/j.bbmt.2013.04.005

Figure 3.

Figure 3

Overall survival, non-relapse mortality, and relapse in patients with AML/MDS conditioned with CY/TBU (n=31) vs. TBU/CY (n=238). Abbreviations: AML, acute myeloid leukemia; MDS, myelodysplastic syndrome; CY, cyclophosphamide; TBU, targeted busulfan.